The aim of this study was to investigate the effi cacy of pre-and posttreatment 99 mTc-ethyl cysteinate dimer ( 99 mTc_ECD) single photon emission computed tomography (SPECT) for predicting the ischemic outcome of embolic middle cerebral artery occlusion after treatment with local in traarterial thrombolysis. The authors examined 28 patients with a moderately ischemic area (ratio of affected regional activity to cerebellar activity (NC ratio) of 0.4 to 0.7) determined using pretreatment SPECT, and with complete recanalization within 6 hours. Posttreatment dynamic and static SPECT studies were performed immediately after thrombolysis. The extent of the affected area outlined on pretreatment SPECT was used for the posttreatment SPECT images, and A/C ratios were calculated. The relative retention ratio of 99 mTc_ECD in the affected area was also analyzed using posttreatment dynamic SPECT. Four-In the treatment of acute ischemic stroke, restoration of cerebral blood flow (CBF) is essential to protect isch emic brain from infarction. Intraarterial thrombolytic therapy has been a useful method for recanalizing oc cluded arteries (del Zoppo et aI.
teen patients either without infarction or with small subcortical and basal ganglial infarction, II patients with medium or large cortical infarction, and 3 patients with hemorrhage were iden tified by follow-up computed tomography. Ischemic outcome correlated with the relative retention ratio of 99 mTc_ECD more closely than either the pre-or posttreatment A/C ratios. In particular, a threshold value for the development of hemorrhage was distinct only in the relative retention ratio of 99 mTc_ECD. Pretreatment 99 InTc_ECD SPECT did not always predict the occurrence of hemorrhagic transformation, whereas dynamic 9 9mTc_ECD SPECT performed immediately after thrombolysis allowed clear identification of patients at risk for hemorrhagic transformation. Key Words: Cerebral embolism-99 InTc ECD-SPECT -Thrombolytic therapy-Hemorrhagic trans formation-Stroke management. et aI., 1999; Furlan et aI., 1999; Veda et aI., 1999; Kidwell et aI., 2000) . However, thrombolytic therapy of acute ischemic stroke is associated with significant mor bidity and mortality. In particular, the greatest problem reportedly has been hemorrhagic transformation, which may result in rapid deterioration of the patient's neuro logic condition (Overgaard et aI., 1990; del Zoppo et aI., 1998; Furlan et a!., 1999; Deda et a!., 1999) .
The reversibility of ischemic brain tissue is known to depend on the intensity and duration of ischemia (Astrup et a!., 1981; Jones et aI., 1981; Weinstein et a!., 1986) .
The former is related to residual blood flow, whereas the latter is related to the timing of treatment. Noninvasive brain perfusion imaging modalities such as single photon emission computed tomography (SPECT), positron emission tomography, and magnetic resonance imaging are expected to have potential value in the assessment of tissue reversibility before treatment (Giubilei et aI., K. OGASAWARA ET AL. 1990 ; Hanson et aI., 1993; Baird et aI., 1994; Grotta and Alexandrov, 1998; Heiss et aI., 1998; Jansen et aI., 1999; Marks et aI., 1999; Ryu et aI., 1999; Kidwell et aI., 2000) . Several retrospective studies using SPECT have established the CBF thresholds for the development of infarction or hemorrhage, and the results have suggested that pretreatment SPECT can provide useful parameters to increase the efficacy of thrombolysis by reducing hemorrhagic complications (Ezura et aI., 1996; Sasaki et aI., 1996; Veda et aI., 1999) . However, no studies to date have reported on the ischemic and neurologic outcomes of patients selected based on the pretreatment CBF as sessment who underwent local intraarterial thrombolysis.
Moreover, studies regarding the relation between isch emic outcome and SPECT findings have exclusively used the tracer 99 mTc-hexamethylpropyleneamine oxime e 9 mTc-HMPAO), which assesses cerebral blood flow (Giubilei et aI., 1990; Hanson et aI., 1993; Baired et aI., 1994; Ezura et aI., 1996; Sasaki et aI., 1996; Grotta and Alexandrov, 1998; Veda et aI., 1999; Ryu et aI., 1999) .
In contrast, the tracer 99 mTc-ethyl cysteinate dimer ( 99 mTc_ECD) reflects not only perfusion but also the metabolic status of brain tissue (Lassen and Sperling, 1994; Nakagawara et aI., 1994; Devous, 1995; Shishido et a!., 1995; Jacquier-Sarlin et aI., 1996) . In a study with a time window of 6 hours after the onset of symptoms, 99 mTc_ECD SPECT was used to produce a clearer dis tinction between transient cerebral ischemia and isch emic infarction (Berrouschot et aI., 1998) . In addition, 99 mTc_ECD has been suggested to be a potential agent with which to evaluate neural tissue viability early after reperfusion of cerebral ischemia (Ogasawara et aI., 1999) .
The aim of the current study was to investigate the efficacy of pre-and posttreatment 99 mTc_ECD SPECT for predicting the ischemic outcome of patients in which a moderately ischemic area because of embolic mid dle cerebral artery occlusion was detected. All cases showed complete recanalization after local intraarterial thrombolysis.
MATERIALS AND METHODS
The authors investigated 34 selected cases involving patients treated at our institution between January 1995, and September 1996, using local intraarterial thrombolysis (LIT) for acute em bolic stroke. Of the 34 patients, 28 who had complete recana lization within 6 hours after the onset of symptoms and were studied with both pre-and posttreatment SPECT were enrolled in the current study. The patients consisted of 8 women and 20 men between 40 and 73 years of age (mean ± SD, 59 ± 11 years).
The inclusion criteria for LIT at the authors' institution were as follows: age less than 75 years; no regions of hypodensity observed on computed tomography scan (CT) upon admission; a mean radioactivity in the entire ischemic area obtained by J Cereb Blood Flow Metab, Vol. 20, No. II, 2000 pretreatment 99 mTc_ECD SPECT after an initial CT of between 40% and 70% compared with that in the ipsilateral cerebellum; sites of occlusion in the middle cerebral artery suggested by symptoms; a diagnosis of embolic occlusion made according to the guidelines of the Cerebral Embolism Task Force (1986) based on the onset pattern, angiographic findings, and results of cardiovascular examinations such as electrocardiography and echocardiography; the patient was treated within 6 hours after the onset of symptoms; and informed consent was obtained from the patient or relatives. The exclusion criteria were as follows: recent hemorrhagic stroke; critical systemic condition; serious disabling disease; and classic contraindications to thrombolytic therapy (recent surgery, gastrointestinal bleeding, or known bleeding tendency).
Local intraarterial thrombolysis was performed using recom binant tissue plasminogen activator (rtPA). Arterial digital sub traction angiography was performed by the Seldinger method using a 5-French catheter and a 6-French femoral sheath. The tip of a Tracker-I 8 catheter (Target Therapeutics, Fremont, CA, U.S,A.) was advanced into the thrombus or upstream from the site of occlusion over a 0.356-cm (0,014-inch) Taper Dasher guide wire (Target Therapeutics). RtPA (1,600,000 IV) was dissolved in 20 mL of physiologic saline and then injected manually for approximately 10 minutes. Angiography was per formed by injection of contrast material through the Tracker-l 8 catheter immediately after each infusion. This was repeated until recanalization of the occluded vessel was confirmed. The maximum dose of rtPA was 4,800,000 IU. The patients were managed initially by administration of 20% mannitol (500 mL), phenytoin (500 mg), and vitamin E (500 mg) during the therapy, Single photon emission computed tomography images were obtained using a multi detector ring-type scanner, of which the detector array consists of 64 NaI crystals in a 38-cm-diameter circle. After tomographic reconstruction, the spatial resolution and slice thickness in the center of the plane were 9 mm and 16 mm full width at half-maximum, respectively, for static imag ing and 20 mm and 25 mm, respectively, for dynamic imaging, The energy window in this study was 140 KeY (±15%). Pro jection data for static and dynamic imaging were processed with Ramachandran's filtered backprojection after introduction of a Butterworth prefilter. A 64 x 64 t 9 mTc-ECD static) or 32
x 32 (99mTc_ECD dynamic) image matrix was used.
Patients were injected with the tracer in a quiet, dimly lit room while resting with their eyes open. The patient's head was immobilized with a ready-made plastic headholder so that bi lateral external auditory meatuses were aligned to the machine indwelling positioning crossed-light beam. To reproduce the same head position during the pre-and posttreatment studies, three markers were affixed on the head under the guidance of a light beam. Of the three markers, two were placed on the anterior edge of the bilateral external auditory meatuses, with the remaining one on the midline of the nose ridge, The three markers lay along a plane perpendicular to the axis of camera rotation, Pretreatment SPECT imaging with a high-resolution colli mator proceeded 10 minutes after intravevous injection of 720 MBq 99 mTc_ECD, Tomographic data were continuously ob tained over a 20-minute period. Of the six axial slices obtained, the slice most clearly demonstrating the ischemic region was selected. Regions of interest (ROls) were drawn by hand both in the apparent entire ischemic area based on qualitative in spection and in the entire cerebellar hemisphere on the isch emic side. The mean count was determined in each region of interest. The ratio of affected regional activity (A) to cerebellar activity (C; A/C ratio) was calculated to evaluate the residual CBF in the entire ischemic region before LIT.
Posttreatment SPECT was performed immediately after LIT. Simultaneously with an additional intravenous bolus injection of 900 MBq 99 mTc_ECD, dynamic scanning with a high sensitivity collimator began and continued for a total of 288 seconds (8 scans) with a scan time duration of 36 seconds. Subsequently, static SPECT was performed using the same procedure as the pretreatment study. Before posttreatment SPECT study, baseline static and dynamic SPECT was per formed (Fig. I) . After reconstruction, the baseline images were subtracted from the images of posttreatment SPECT study, af ter correcting for time differences in data acquisition to exclude any influence of the tracer retained in the brain on the pretreat ment study and to obtain "true" posttreatment 99 mTc_ECD SPECT images. Of the six axial slices obtained, the slice cor responding to the slice chosen in pretreatment SPECT images was selected, and ROls identical with those of pretreatment SPECT were visually and manually set to the posttreatment SPECT images by two observers blind to the clinical charac teristics and CT findings. The mean count was determined in each ROI, and the NC ratio was calculated in posttreatment static SPECT images. Furthermore, the second and eighth of eight posttreatment dynamic scans were selected. The relative retention ratio in the affected area was calculated as follows:
A in the 8th scan/ A in the 2nd scan CO in the 8th scan/CO in the 2nd scan where A is the mean count in the ROIs on the affected side, and CO is the mean count in the corresponding region on the con tralateral side.
A CT scan was performed immediately after therapy, the next day, I week, 2 weeks, and I month after therapy. The patient's neurologic status was evaluated upon admission, the next day, and I month after treatment, according to the Na tional Institutes of Health (NIH) Stroke Scale (Brott et aI., 1989) , which expresses the severity of neurologic status nu merically from 0 (normal) to 42. An NIH score of 42 points was assigned to patients who had died within I month of treatment.
For statistical analysis, the values were expressed as the mean ± SD, and differences among the three groups were ex amined by Scheffe's F test. Statistical significance was set at P < 0.05.
RESULTS
Based on the follow-up CT, the patients were classi fied into three groups: (A) 14 patients with no evidence The A/C ratio obtained by pretreatment SPECT statis tically differentiated the reversible ischemia group from the cortical infarction and hemorrhagic groups. The mean value was less in the hemorrhagic group than in the cortical infarction group. However, the difference be tween the two groups in terms of ischemic duration be tween 3 and 6 hours was not statistically significant.
Even when patients were separated into two subgroups according to a duration of ischemia cutoff value of 4.5 hours, the difference in the pretreatment A/C ratio be tween the cortical infarction and hemorrhagic groups did not reach the level of significance, and it was impossible to identify a threshold value for the development of hem orrhage (Fig. 2) .
The A/C ratio obtained by posttreatment static SPECT statistically differentiated the reversible ischemia group from both the cortical infarction and hemorrhagic groups. However, the observed threshold value for the development of cortical infarction was not distinct (Fig.   3 ). Furthermore, the difference between the cortical in farction and hemorrhagic groups was not statistically significant.
The relative retention ratio of 99mTc_ECD in the af fected area obtained by posttreatment dynamic SPECT statistically differentiated all three groups. Ischemic out come depended on the relative retention ratio. The thresholds for the development of infarction or hemor rhage were 0.95 and 0.75 of the relative retention ratio, respecti vely (Fig. 4) . Representative images in cases of hemorrhagic transformation are shown in Fig. 5 .
DISCUSSION
The current findings demonstrated that CBF param eters obtained by pretreatment 99mTc_ECD SPECT can be used to differentiate patients with reversible ischemia from those with irreversible brain damage. However, it intervention can be initiated to limit brain damage (Ueda et aI., 1999) . Within this therapeutic window, it is pre sumed that most ischemic tissue remains viable, and thus theoretically can be revived. However, in recent studies using local intraarterial thrombolytic therapy, not all of Ueda et aI., 1999) . Several retrospective studies have demonstrated that within 6 hours after the onset of symp toms, the threshold value for the development of hem orrhage was likely to be approximately 0.4 of residual relative regional CBF (Ezura et aI., 1996; Sasaki et a!., 1996; Ueda et aI., 1999) . In the current study, only pa tients verified to have a moderately ischemic area as determined by an AlC ratio between 0.4 and 0.7, based on the pretreatment CBF assessment, were selected for local intraarterial thrombolytic therapy. The current data showed that hemorrhage occurred in 11% (3 of 28) of patients. The rate of hemorrhagic complication was less (22% to 43%) compared with that of patients who un derwent local intraarterial thrombolysis regardless of pretreatment CBF, with complete recanalization obtained within 6 hours after the onset of symptoms (Sasaki et a!., 1996; Furlan et a!., 1999; Ueda et a!., 1999) . These find ings suggest that pretreatment 99 mTc_ECD SPECT pro vides useful parameters to increase the efficacy of throm bolysis by reducing hemorrhagic complications. How ever, the authors' result of an indistinct threshold between pretreatment CBF for the development of in farction and that of hemorrhage was inconsistent with previous findings (Ezura et aI., 1996; Ueda et a!., 1999) .
Possible sources of this inconsistency are a difference in the tracers used for pretreatment CBF assessment, the methods of establishing ROIs, and the number of en rolled patients. However, the authors consider the most plausible cause of an indistinct threshold between pre treatment CBF for the development of infarction and that of hemorrhage to be the following: the regional CBF, after sudden occlusion of the main trunk of the cerebral artery, is not constant and changes in a nonspecific man ner depending on the efficacy of collateral blood supply through the meningo-pial anastomosis (Heiss et aI., 2000) . In addition. fragmentation and migration of em boli have been documented clinically and experimentally (Bladin, 1964; Liebeskind et aI.. 1971; Kaneko et aI., 1985) . Single photon emission computed tomography images can show moderate ischemia in the affected side in a patient with severe ischemia due to embolic internal carotid artery occlusion at the onset, when migration of the embolus into the trunk of the middle cerebral artery has occurred before pretreatment SPECT study. There fore, CBF data obtained by pretreatment SPECT does not always reflect average perfusion from onset to recanali zation. The authors believe that there is a limit to the degree to which they can prospectively identify patients at risk for hemorrhage after local intraarterial thromboly sis using pretreatment SPECT.
Interestingly, in the current study, the threshold value for the development of hemorrhage was not distinct in posttreatment static 99 mTc_ECD SPECT images, but was distinct in posttreatment dynamic 99 mTc_ECD SPECT images. 99 I11 Tc_ECD is transformed by intracellular es terases from a diester into a diacid complex. This polar metabolite does not cross the cell membrane and there fore is trapped in the neural cell (Walovitch et aI.. 1989; Jacquier-Sarlin et aI., 1996) . The brain distribution of SPECT images show that tracer activity in the le sion rapidly decreases to less than that in the con tralateral area. The relative retention ratio was 0.72.
(C)
A computed tomography scan obtained the day after treatment shows hemorrhagic transformation in the left middle cerebral artery territory with left hemispheric edema.
Therefore, it is impossible to judge which of the above two factors more strongly affects the focally decreased uptake of 99 mTc_ECD in each static SPECT image. How ever, the relative retention ratio of 99 mTc_ECD obtained by dynamic SPECT is presumably influenced only by the activity of cytosolic esterase and the severity of blood brain barrier breakdown. The extremely decreased rela tive retention ratio of 99 mTc_ECD in the reperfused area thus indicates ongoing irreversible severe brain damage, which in turn leads to hemorrhagic transformation.
Reliable information on the prognosis of an ischemic area after local intraarterial thrombolysis is urgently re quired as hemorrhagic transformation may result in rapid deterioration of the patient' s neurologic condition (Over gaard et a!., 1990; del Zoppo et a!., 1998; Furlan et aI., 1999; Ueda et aI., 1999) . Specific, but potentially dan gerous, treatments such as decompressive hemicraniec tomy (Delashaw et aI., 1990) or mild hypothermia (Schwab et aI., 1997) appear to be more appropriate for those patients. In cases in which a diagnosis of hemor rhagic transformation is confirmed early after throm bolysis, the patient should be transferred immediately to an intensive care unit or to any specially equipped center where decompressive hemicraniotomy or mild hypother mia can be performed (Berrouschot et aI., 1998) . Dy namic 99 mTc_ECD SPECT performed immediately after local intraarterial thrombolysis enables accurate identifi cation of patients at risk for hemorrhagic transformation, which in turn allows clinicians to immediately initiate treatment that may be specific for increasing intracranial pressure.
The procedure used for dynamic SPECT imaging in the current study is accomplished in 10 minutes, includ ing the baseline study, and is not uncomfortable even for critical patients. In recent years, a multihead gamma camera with high sensitivity and spatial resolution has been developed. Such advances will enable dynamic SPECT images to be obtained routinely in many institu tions in the near future.
In conclusion, pretreatment 99 mTc_ECD SPECT does not always predict the occurrence of hemorrhagic trans formation, whereas dynamic 99 mTc_ECD SPECT per formed immediately after thrombolysis allows for clear identification of patients at risk for hemorrhagic trans formation.
